Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response.


Journal

Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300

Informations de publication

Date de publication:
13 04 2021
Historique:
received: 29 12 2020
revised: 23 02 2021
accepted: 24 02 2021
entrez: 14 4 2021
pubmed: 15 4 2021
medline: 27 4 2021
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leading to coronavirus disease 2019 (COVID-19) usually results in respiratory disease, but extrapulmonary manifestations are of major clinical interest. Intestinal symptoms of COVID-19 are present in a significant number of patients, and include nausea, diarrhea, and viral RNA shedding in feces. Human induced pluripotent stem cell-derived intestinal organoids (HIOs) represent an inexhaustible cellular resource that could serve as a valuable tool to study SARS-CoV-2 as well as other enteric viruses that infect the intestinal epithelium. Here, we report that SARS-CoV-2 productively infects both proximally and distally patterned HIOs, leading to the release of infectious viral particles while stimulating a robust transcriptomic response, including a significant upregulation of interferon-related genes that appeared to be conserved across multiple epithelial cell types. These findings illuminate a potential inflammatory epithelial-specific signature that may contribute to both the multisystemic nature of COVID-19 as well as its highly variable clinical presentation.

Identifiants

pubmed: 33852884
pii: S2213-6711(21)00099-0
doi: 10.1016/j.stemcr.2021.02.019
pmc: PMC8042780
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

940-953

Subventions

Organisme : NIAID NIH HHS
ID : UC7 AI095321
Pays : United States
Organisme : NIH HHS
ID : N0175N92020C00005
Pays : United States
Organisme : NIH HHS
ID : 1R01DA051889-01
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Cell Host Microbe. 2016 Feb 10;19(2):181-93
pubmed: 26867177
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Virol. 2020 Sep 15;94(19):
pubmed: 32699094
Cell. 2020 Nov 25;183(5):1325-1339.e21
pubmed: 33080218
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Biochem Biophys Res Commun. 2020 May 21;526(1):135-140
pubmed: 32199615
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell Stem Cell. 2020 Jul 2;27(1):125-136.e7
pubmed: 32579880
Am J Gastroenterol. 2020 May;115(5):766-773
pubmed: 32287140
Clin Gastroenterol Hepatol. 2020 Oct 1;:
pubmed: 33010411
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Lancet. 2020 Aug 1;396(10247):320-332
pubmed: 32682491
J Virol. 2015 Dec;89(23):11820-33
pubmed: 26378163
Cell Rep. 2020 Jul 7;32(1):107863
pubmed: 32610043
J Gen Virol. 2012 Dec;93(Pt 12):2601-2605
pubmed: 22956738
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
mBio. 2014 May 20;5(3):e01174-14
pubmed: 24846384
Gastroenterology. 2020 Oct;159(4):1302-1310.e5
pubmed: 32598884
J Clin Invest. 2020 Dec 1;130(12):6290-6300
pubmed: 32784290
Gastroenterology. 2020 Sep;159(3):1151-1154.e2
pubmed: 32413354
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
Mol Cell. 2021 Jan 7;81(1):212
pubmed: 33417854
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Cell Stem Cell. 2020 Dec 3;27(6):962-973.e7
pubmed: 32979316
Bioinformatics. 2017 Jul 1;33(13):2050-2052
pubmed: 28203714
Nat Med. 2020 Jul;26(7):1077-1083
pubmed: 32405028
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Nature. 2021 Jan;589(7841):270-275
pubmed: 33116299
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Gut. 2021 Apr;70(4):698-706
pubmed: 33431578
Gastroenterology. 2021 Jan;160(1):287-301.e20
pubmed: 32980345
Nat Commun. 2020 Jul 30;11(1):3810
pubmed: 32733001
Nat Commun. 2020 Jan 10;11(1):215
pubmed: 31924806
Nature. 2012 Jul 25;487(7408):477-81
pubmed: 22837003
Gastroenterology. 2020 Jul;159(1):373-375.e2
pubmed: 32294477
J Pathol. 2001 Jan;193(1):134-40
pubmed: 11169526
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
J Pathol. 2004 Jul;203(3):740-3
pubmed: 15221932
Gastroenterology. 2020 May;158(6):1831-1833.e3
pubmed: 32142773

Auteurs

Aditya Mithal (A)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA; Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA.

Adam J Hume (AJ)

National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA; Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA.

Jonathan Lindstrom-Vautrin (J)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA.

Carlos Villacorta-Martin (C)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA.

Judith Olejnik (J)

National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA; Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA.

Esther Bullitt (E)

Department of Physiology & Biophysics, Boston University School of Medicine, Boston, MA 02118, USA.

Anne Hinds (A)

The Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.

Elke Mühlberger (E)

National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA; Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: muehlber@bu.edu.

Gustavo Mostoslavsky (G)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA; Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA; Section of Gastroenterology, Department of Medicine, Boston University School of Medicine, Boston, MA 02218, USA. Electronic address: gmostosl@bu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH